Point72 Hong Kong LTD Agios Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $82,585 - $144,514	4,233 Added 242.58%	5,978 $169,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $29,769 - $54,827	1,745 New	1,745 $39,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $40,366 - $52,667	-1,513 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $30,526 - $51,372	1,032 Added 214.55%	1,513 $50,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $116,202 - $161,274	-2,772 Reduced 85.21%	481 $22,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $169,351 - $199,311	3,253 New	3,253 $179,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $172,452 - $224,192	-3,899 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $190,525 - $266,999	-5,737 Reduced 59.54%	3,899 $169,000
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $326,371 - $538,941	9,636 New	9,636 $337,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $26,079 - $43,861	-867 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $28,090 - $42,985	867 New	867 $28,000
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $5,785 - $8,526	-126 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $5,383 - $9,642	126 New	126 $6,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $29,384 - $37,699	-410 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $3,148 - $4,280	-43 Reduced 9.49%	410 $35,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $21,778 - $31,496	364 Added 408.99%	453 $37,000
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $7,922 - $10,994	-152 Reduced 63.07%	89 $5,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $13,228 - $16,175	241	241 $16,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.